Live Breaking News & Updates on Ares Genetics

Stay updated with breaking news from Ares genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CORRECTION – OpGen Reports Fourth Quarter and Full Year

ROCKVILLE, Md., March 30, 2023 (GLOBE NEWSWIRE) In a release published March 29, 2023 under the same headline by OpGen, Inc. (Nasdaq: OPGN), the. ....

Oliver Schacht , Curetis Gmb , Albert Weber , Gene Panel , Opgen Investor Press Contact , Edison Group , European Investment Bank , International Number , Exchange Commission , Securities Exchange , Technology Platform , Opgen Inc , Foundation For Innovative New Diagnostics , Full Year , Chief Financial Officer , Beijing Clear Biotech , Ares Genetics , Innovative New Diagnostics , Dial In Number , United Statesa , Curetis Gmbh , Ares Genetics Gmbh , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Nasdaq Capital Market ,

CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Albert Weber , Curetis Gmb , Oliver Schacht , Gene Panel , Opgen Investor Press Contact , Edison Group , European Investment Bank , Securities Exchange , Technology Platform , Exchange Commission , International Number , Opgen Inc , Foundation For Innovative New Diagnostics , Full Year , Chief Financial Officer , Beijing Clear Biotech , Ares Genetics , Innovative New Diagnostics , Dial In Number , United Statesa , Curetis Gmbh , Ares Genetics Gmbh , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Nasdaq Capital Market ,

CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Oliver Schacht , Oliver Schachtpresident , Curetis Gmb , Albert Weber , Exchange Commission , International Number , Technology Platform , Foundation For Innovative New Diagnostics , Gene Panel , Opgen Investor Press Contact , Alyssa Factoredison Group , European Investment Bank , Securities Exchange , Opgen Inc , Full Year , Chief Financial Officer , Beijing Clear Biotech , Ares Genetics , Innovative New Diagnostics , Dial In Number , United Statesa , Curetis Gmbh , Ares Genetics Gmbh , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act ,

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Curetis Gmb , Albert Weber , Oliver Schacht , European Investment Bank , International Number , Exchange Commission , Securities Exchange , Technology Platform , Opgen Inc , Foundation For Innovative New Diagnostics , Gene Panel , Opgen Investor Press Contact , Edison Group , Full Year , Chief Financial Officer , Beijing Clear Biotech , Ares Genetics , Innovative New Diagnostics , Dial In Number , United Statesa , Curetis Gmbh , Ares Genetics Gmbh , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Nasdaq Capital Market ,

OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Total revenue for 2022 was approximately $2.6 millionBalance sheet strengthened by recently closed public offering with gross proceeds of $7.5 millionConference call to be held March. | March 29, 2023 ....

Curetis Gmb , Oliver Schacht , Albert Weber , Gene Panel , International Number , Foundation For Innovative New Diagnostics , European Investment Bank , Securities Exchange , Opgen Investor Press Contact , Technology Platform , Opgen Inc , Exchange Commission , Edison Group , Full Year , Chief Financial Officer , Beijing Clear Biotech , Ares Genetics , Innovative New Diagnostics , Dial In Number , United Statesa , Curetis Gmbh , Ares Genetics Gmbh , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Nasdaq Capital Market ,